Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “D3 Dopamine Receptor”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)Active Not RecruitingNCT02379338
What this trial is testing

Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT

Who this might be right for
Healthy
University of Pennsylvania 29
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Early research (Phase 1)Ended earlyNCT03059563
What this trial is testing

Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

Who this might be right for
Dopamine D2/3 Receptor AvailabilityCognitive FunctionMethamphetamine Abuse
University of California, Los Angeles 62
Not applicableLooking for participantsNCT03537794
What this trial is testing

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Unity Health Toronto 45
Testing effectiveness (Phase 2)Study completedNCT01699828
What this trial is testing

Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

Who this might be right for
Smoking CessationTobacco Use Cessation
Centre for Addiction and Mental Health 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02815917
What this trial is testing

Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT

Who this might be right for
D3 Dopamine ReceptorCocaine-dependentHealthy Volunteer
University of Pennsylvania 30
Not applicableStudy completedNCT01984177
What this trial is testing

Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence

Who this might be right for
Cocaine-Related DisordersCocaine AddictionSubstance-Related Disorders
Centre for Addiction and Mental Health 17
Testing effectiveness (Phase 2)Study completedNCT03544229
What this trial is testing

Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

Who this might be right for
Diabetic GastroparesisIdiopathic Gastroparesis
Millennium Pharmaceuticals, Inc. 242
Early research (Phase 1)Study completedNCT00814957
What this trial is testing

An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand

Who this might be right for
Substance Dependence
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00468806
What this trial is testing

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

Who this might be right for
Healthy Subjects
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07626034
What this trial is testing

A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

Who this might be right for
Schizophrenia Disorder
Shanghai Zhongze Therapeutics Co., Ltd. 9
Early research (Phase 1)Study completedNCT06261905
What this trial is testing

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Who this might be right for
Opioid Use Disorder
Yale University 5
Not applicableStudy completedNCT03037060
What this trial is testing

Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study

Who this might be right for
Alcohol Use Disorder
Centre for Addiction and Mental Health 17
Early research (Phase 1)Study completedNCT00471588
What this trial is testing

Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors

Who this might be right for
Obsessive-Compulsive Disorder
GlaxoSmithKline 52
Not applicableStudy completedNCT00001320
What this trial is testing

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Who this might be right for
HealthySchizophrenia
National Institute of Mental Health (NIMH) 265
Early research (Phase 1)Study completedNCT06300580
What this trial is testing

Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
AbbVie 11
Post-approval studies (Phase 4)WithdrawnNCT05060549
What this trial is testing

Dopamine D3 Receptor Occupancy in Bipolar Depression

Who this might be right for
Bipolar Depression
New York State Psychiatric Institute